Zurueck zur Suche

Reporte zur Charge 49N3S

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
GA 2 CA 2 WA 2 FL 2 AL 1 MO 1 OR 1 LA 1

VAERS 2375019

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

moderat
Staat
GA
Alter
59,0
Geschlecht
M
Eingang
20.07.2022
Impfdatum
12.07.2022
Beginn
13.07.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue Pyrexia Tremor

Symptomtext

Patient describes having fever, tremors and extreme fatigue after getting shingrix vaccine for 1-2 days. Patient stated onset was that evening. Patient called ambulance, but they did not transport him to hospital. Patient then recovered after approx 2 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
Unknown
Andere Medikamente
N/A, patient does not fill RX here
Allergien
NKA
Vorherige Impfungen
-

VAERS 2386764

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49n3s

mild
Staat
CA
Alter
52,0
Geschlecht
F
Eingang
23.07.2022
Impfdatum
06.07.2022
Beginn
06.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Diarrhoea Fatigue Neck pain Pain in extremity Rash Vomiting

Symptomtext

Vomiting; Diarrhea; Rash that started at her elbow and extended to just below the injection site; Tiredness; Pain in injection arm that went from elbow to her neck; Pain in injection arm that went from elbow to her neck; Pain in injection arm that went from elbow to her neck; This case was reported by a pharmacist via call center representative and described the occurrence of vomiting in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number 49n3s, expiry date 24th August 2023) for prophylaxis. On 6th July 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 6th July 2022, several hours after receiving Shingrix, the patient experienced vomiting, diarrhea, rash, tiredness, neck pain, pain in elbow and pain in arm. On an unknown date, the outcome of the vomiting, diarrhea, tiredness, neck pain, pain in elbow and pain in arm were recovered/resolved and the outcome of the rash was not recovered/not resolved. It was unknown if the reporter considered the vomiting, diarrhea, rash, tiredness, neck pain, pain in elbow and pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 11-Jul-2022 Reporter's Comments: The patient received Shingrix vaccine in left arm. The patient stated that several hours after getting the vaccine, the patient started with vomiting, diarrhea, and tiredness. These symptoms had been resolved. The patient also reported that she had pain in the injection arm that went from elbow to her neck and a rash that started at her elbow and extended to just below the injection site. The pain had subsided, but the rash was still there. The consent to follow up was given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2296526

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

mild
Staat
GA
Alter
55,0
Geschlecht
M
Eingang
26.05.2022
Impfdatum
22.05.2022
Beginn
23.05.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Rash papular Skin discolouration

Symptomtext

PATIENT HAS SHINGLES-LIKE MARKINGS ON RIGHT ARM ONLY. THE MARKINGS WERE SWOLLEN/RASIED BUT HAS FLATTENED AND DARKENED. PATIENT EXPRESSED PREVIOUS ITCHING SENSATION BUT DID NOT SCRATCH TO CREATE OPEN WOUNDS. PATIENT DESCRIBED SEEING THIS <24 HOURS AFTER VACCINE ADMINISTRATION ON 5/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
DIABETES
Vorgeschichte
DIABETES
Andere Medikamente
BYDUREON, JARDIANCE, ROSUVASTATIN, ATENOLOL/CHLORTHALIDONE, METFORMIN, BASAGLAR
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2283262

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49n3s

mild
Staat
AL
Alter
60,0
Geschlecht
F
Eingang
18.05.2022
Impfdatum
12.05.2022
Beginn
13.05.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash pruritic

Symptomtext

She developed an itchy rash. She put rubbing alcohol on it. I recommended using either a topical or oral antihistamine. The rash has not resolved. Advised her if it does not clear in another few days to consult a physician

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash pruritic
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2279053

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

mild
Staat
CA
Alter
70,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
09.05.2022
Beginn
15.05.2022
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

rash down back of legs from buttocks

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Aspirin 81 mg.
Allergien
-
Vorherige Impfungen
-

VAERS 2277843

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

mild
Staat
MO
Alter
57,0
Geschlecht
M
Eingang
15.05.2022
Impfdatum
10.05.2022
Beginn
11.05.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site rash Injection site swelling Skin weeping

Symptomtext

Redness, pain, swelling, and rash localized to the injection site. There was some oozing from the rash as well. Patient had a case of shingles in the past with similar presentation on his leg.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2680577

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

gering
Staat
OR
Alter
-
Geschlecht
F
Eingang
08.09.2023
Impfdatum
30.08.2023
Beginn
30.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Shingrix that expired on 8/24/2023 was administered to a female patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a adult female patient who received Herpes zoster (Shingrix) (batch number 49N3S, expiry date 24-AUG-2023) for prophylaxis. On 30-AUG-2023, the patient received the 1st dose of Shingrix. On 30-AUG-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: Shingrix that expired on 8/24/2023 was administered to a female patient). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 01-Sept-2023 The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up via postal. The patient received an expired dose of Shingrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2572697

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

gering
Staat
LA
Alter
-
Geschlecht
M
Eingang
01.02.2023
Impfdatum
26.06.2022
Beginn
26.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

2nd dose given less than 1 month after 1st; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number 49N3S, expiry date 24th August 2023) for prophylaxis. Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX). On 26th June 2022, the patient received the 2nd dose of Shingrix. On 26th June 2022, unknown after receiving Shingrix and an unknown time after receiving SHINGRIX, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional Information: GSK receipt date: 24-Jan-2023 Reporter's comment: The patient received first dose of Shingrix on 7th June 2022 and the second dose was administered on 26th June 2022. Pharmacist informed that patient did not report adverse events. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter. Additional supportive information: the patient received 2nd dose on 26th June 2022 and received 1st dose on 7th June 2022, which led to drug dose administration interval too short.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2416657

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

gering
Staat
WA
Alter
-
Geschlecht
F
Eingang
20.08.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

received a third dose of Shingrix in error; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number 49N3S, expiry date 24th August 2023) for prophylaxis. On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. Additional Information: GSK Receipt Date: 12-AUG-2022 Reporter's Comments: The patient received a third dose of Shingrix in error. The reporter was not asked about follow-up. Additional Supportive Information: The patient received 3rd dose of Shingrix, which led to extra dose administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2313429

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

gering
Staat
FL
Alter
56,0
Geschlecht
M
Eingang
08.06.2022
Impfdatum
08.06.2022
Beginn
08.06.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient has no reaction at the time of administration. However, this is his 3rd dose and he shouldn't have received a 3rd dose. He already received 2 doses back in 2020.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
vitamin D 50,000 IU
Allergien
NKDA no allergies
Vorherige Impfungen
-

VAERS 2262394

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49n3s

gering
Staat
WA
Alter
62,0
Geschlecht
M
Eingang
03.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

patient entered pharmacy wanting to get shingle shot and he said he never got it. So we tested the claim to see if it covered by his insurance and it was covered. After giving shingle vaccine, I saw his profile that he has gotten 2 series shots in 6/21/2019 and 11/5/2019

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
no
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
none
Allergien
no
Vorherige Impfungen
-

VAERS 2195995

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 49N3S

gering
Staat
FL
Alter
76,0
Geschlecht
F
Eingang
24.03.2022
Impfdatum
22.03.2022
Beginn
22.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product preparation issue

Symptomtext

only received adjuvant; only received adjuvant; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 76-year-old female patient who received Herpes zoster (Shingrix) (batch number 49N3S, expiry date 24th August 2023) for prophylaxis. On 22nd March 2022, the patient received the 1st dose of Shingrix. On 22nd March 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional details were provided as follows: The reporter stated that a patient only received a single-dose vial of adjuvant suspension component and they did not reconstitute the vial of lyophilized gE antigen component of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-